Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift

Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift

The study was to explore the rational use of danofloxacin against <i>Mycoplasma gallisepticum</i> (<i>MG</i>) based on its clinical breakpoint (CBP) and the effect on lung microbiota. The CBP was established according to epidemiological cutoff value (ECV/CO<sub>WT</s...

Full description

Bibliographic Details
Main Authors: Shuge Wang, Anxiong Huang, Yufeng Gu, Jun Li, Lingli Huang, Xu Wang, Yanfei Tao, Zhenli Liu, Congming Wu, Zonghui Yuan, Haihong Hao
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Antibiotics
Subjects:
danofloxacin
<i>Mycoplasma gallisepticum</i>
epidemiological cutoff values
PK–PD cutoff values
clinical cutoff values
clinical breakpoint
Online Access:https://www.mdpi.com/2079-6382/11/3/403

Internet

https://www.mdpi.com/2079-6382/11/3/403

Similar Items